Top

Clinical Oral Investigations

Published in:

01-06-2017 | Original Article

Osteogenic potential of recombinant human bone morphogenetic protein-9/absorbable collagen sponge (rhBMP-9/ACS) in rat critical size calvarial defects

Authors: Toshiaki Nakamura, Yoshinori Shirakata, Yukiya Shinohara, Richard J. Miron, Kirara Furue, Kazuyuki Noguchi

Published in: Clinical Oral Investigations | Issue 5/2017

Abstract

Objectives

It has been reported that bone morphogenetic protein (BMP)-9 has potent osteoinductive properties among the BMP family by adenovirus-transfection experiments. We very recently reported that absorbable collagen sponge (ACS) as a carrier for recombinant human (rh) BMP-9, compared with chitosan sponge, was suitable for inducing bone healing/regeneration by BMP-9 in a rat calvarial defect model. The aim of this study was to evaluate different doses of rhBMP-9/ACS on new bone formation in rat critical size calvarial defects.

Materials and methods

Bilateral calvarial defects (n = 32) were surgically created in 16 wistar rats and randomly filled with one of the following materials: (1) absorbable collagen sponge (ACS) alone; (2) 1 μg-rhBMP-9/ACS (L-rhBMP-9/ACS); (3) 5 μg-rhBMP-9/ACS (H-rhBMP-9/ACS); and (4) blank defects (control). The animals were sacrificed 8 weeks postsurgery for radiographic and histomorphometric analyses.

Results

Bone volume and defect closure were statistically higher in the rhBMP-9/ACS-implanted (L-rhBMP-9/ACS and H-rhBMP-9/ACS) groups when compared with ACS-alone group (p < 0.05). Furthermore, defects filled with H-rhBMP-9/ACS showed the highest levels of newly formed bone area (NBA) and NBA/total defect area among all groups. No significant differences in any of the radiographic and histometric parameters could be observed between both concentrations of rhBMP-9.

Conclusions

Within the limits of this study, it can be concluded that rhBMP-9/ACS-induced bone formation can be reached with as little as 1 μg/site in rat critical size calvarial defects.

Clinical relevance

RhBMP-9 could be a potential therapeutic growth factor for future bone regenerative procedures.

Deschaseaux F, Sensebe L, Heymann D (2009) Mechanisms of bone repair and regeneration. Trends Mol Med 15:417–429CrossRefPubMed

Herford AS, Boyne PJ (2008) Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66:616–624CrossRefPubMed

Dickinson BP, Ashley RK, Wasson KL, O’Hara C, Gabbay J, Heller JB, Bradley JP (2008) Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 121:209–217CrossRefPubMed

McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop 31:729–734CrossRefPubMedPubMedCentral

Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP et al (2004) Characterization of the distinct orthotopic bone-forming activity of 14 B.P. using recombinant adenovirus-mediated gene delivery. Gene Ther 11:1312–1320CrossRefPubMed

Lamplot JD, Qin J, Nan G, Wang J, Liu X, Yin L, Tomal J, Li R, Shui W, Zhang H et al (2013) BMP9 signaling in stem cell differentiation and osteogenesis. Am J Stem Cells 2:1–21PubMedPubMedCentral

Lopez-Coviella I, Berse B, Krauss R, Thies RS, Blusztajn JK (2000) Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 289:313–316CrossRefPubMed

Lord E, Bergeron E, Senta H, Park H, Faucheux N (2010) Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes. Growth Factors 28:149–156CrossRefPubMed

Majumdar MK, Wang E, Morris EA (2001) BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol 189:275–284CrossRefPubMed

10.

Chen C, Grzegorzewski KJ, Barash S, Zhao Q, Schneider H, Wang Q, Singh M, Pukac L, Bell AC, Duan R et al (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat Biotechnol 21:294–301CrossRefPubMed

11.

Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ, Bailly S (2012) BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119:6162–6171CrossRefPubMedPubMedCentral

12.

Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC, He TC (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25:665–677CrossRefPubMed

13.

Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P et al (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A:1544–1552CrossRefPubMed

14.

Wang Y, Hong S, Li M, Zhang J, Bi Y, He Y, Liu X, Nan G, Su Y, Zhu G et al (2013) Noggin resistance contributes to the potent osteogenic capability of BMP9 in mesenchymal stem cells. J Orthop Res 31:1796–1803PubMed

15.

Nakamura T, Shinohara Y, Momozaki S, Yoshimoto T, Noguchi K (2013) Co-stimulation with bone morphogenetic protein-9 and FK506 induces remarkable osteoblastic differentiation in rat dedifferentiated fat cells. Biochem Biophys Res Commun 440:289–294CrossRefPubMed

16.

Rosen V (2006) BMP and BMP inhibitors in bone. Ann N Y Acad Sci 1068:19–25CrossRefPubMed

17.

Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA (2003) Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10:1735–1743CrossRefPubMed

18.

Fujioka-Kobayashi M, Sawada K, Kobayashi E, Schaller B, Zhang Y, Miron, RJ (2016) Recombinant human bone morphogenetic protein 9 (rhBMP9) induced osteoblastic behaviour on a collagen membrane compared with rhBMP2. J Periodontol 87:e101–e107

19.

Shinohara Y, Nakamura T, Shirakata Y, Noguchi K (2016) Bone healing capabilities of recombinant human bone morphogenetic protein-9 (rhBMP-9) with a chitosan or collagen carrier in rat calvarial defects. Dent Mater J 35:454–460CrossRefPubMed

20.

Artzi Z, Kozlovsky A, Nemcovsky CE, Moses O, Tal H, Rohrer MD, Prasad HS, Weinreb M (2008) Histomorphometric evaluation of natural mineral combined with a synthetic cell-binding peptide (P-15) in critical-size defects in the rat calvaria. Int J Oral Maxillofac Implants 23:1063–1070PubMed

21.

Pelaez M, Susin C, Lee J, Fiorini T, Bisch FC, Dixon DR, McPherson JC 3rd, Buxton AN, Wikesjo UM (2014) Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model. J Clin Periodontol 41:827–836CrossRefPubMed

22.

Hyun SJ, Han DK, Choi SH, Chai JK, Cho KS, Kim CK, Kim CS (2005) Effect of recombinant human bone morphogenetic protein-2, −4, and −7 on bone formation in rat calvarial defects. J Periodontol 76:1667–1674CrossRefPubMed

23.

Rothamel D, Schwarz F, Sager M, Herten M, Sculean A, Becker J (2005) Biodegradation of differently cross-linked collagen membranes: an experimental study in the rat. Clin Oral Implants Res 16:369–378CrossRefPubMed

24.

Shiozaki Y, Kitajima T, Mazaki T, Yoshida A, Tanaka M, Umezawa A, Nakamura M, Yoshida Y, Ito Y, Ozaki T et al (2013) Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4. Int J Nanomedicine 8:1349–1360PubMedPubMedCentral

25.

Tumialan LM, Rodts GE (2007) Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion. Spine J 7:509–510CrossRefPubMed

26.

Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG (2006) Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31:2813–2819CrossRefPubMed

27.

McClellan JW, Mulconrey DS, Forbes RJ, Fullmer N (2006) Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 19:483–486CrossRefPubMed

28.

Leblanc E, Trensz F, Haroun S, Drouin G, Bergeron E, Penton CM, Montanaro F, Roux S, Faucheux N, Grenier G (2011) BMP-9-induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment. J Bone Miner Res 26:1166–1177CrossRefPubMed

Title: Osteogenic potential of recombinant human bone morphogenetic protein-9/absorbable collagen sponge (rhBMP-9/ACS) in rat critical size calvarial defects
Authors: Toshiaki Nakamura
Yoshinori Shirakata
Yukiya Shinohara
Richard J. Miron
Kirara Furue
Kazuyuki Noguchi
Publication date: 01-06-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 5/2017
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-016-1963-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Osteogenic potential of recombinant human bone morphogenetic protein-9/absorbable collagen sponge (rhBMP-9/ACS) in rat critical size calvarial defects

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 5/2017

Mini dental assessment: a simple screening test for non-dental staff

Herpesviral-bacterial co-infection in mandibular third molar pericoronitis

No evidence for the growth-stimulating effect of monomers on cariogenic Streptococci

The mycobiome of root canal infections is correlated to the bacteriome

Effect of non-surgical periodontal treatment by full-mouth disinfection or scaling and root planing per quadrant in halitosis—a randomized controlled clinical trial

Cytocompatibility of calcium silicate-based sealers in a three-dimensional cell culture model